RBC Capital Sticks to Its Buy Rating for Intuitive Surgical (ISRG)
In a report released on February 24, Shagun Singh Chadha from RBC Capital maintained a Buy rating on Intuitive Surgical, with a price target of $650.00. The company’s shares closed yesterday at $494.02.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
According to TipRanks, Singh Chadha is a 4-star analyst with an average return of 3.4% and a 52.88% success rate. Singh Chadha covers the Healthcare sector, focusing on stocks such as Inspire Medical Systems, Becton Dickinson, and Boston Scientific.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Intuitive Surgical with a $647.56 average price target, a 31.08% upside from current levels. In a report released on February 18, BTIG also maintained a Buy rating on the stock with a $616.00 price target.
Based on Intuitive Surgical’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $2.87 billion and a net profit of $794.8 million. In comparison, last year the company earned a revenue of $2.41 billion and had a net profit of $685.7 million
Read More on ISRG:
Disclaimer & DisclosureReport an Issue
- Intuitive Surgical price target lowered to $570 from $600 at UBS
- IHI, IHE, ARKG: Specialty Healthcare ETFs Can Help Boost a Portfolio
- MSFT Stock in the Spotlight as Microsoft Builds Its Own AI Model and Targets Healthcare
- Netflix, Cisco, ISRG, Visa, P&G Trending With Analysts
- Intuitive Surgical initiated with a Buy at TD Cowen
